AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021
Nov 19, 2021
32782_dirs_2021-11-19_075601c4-c191-48d5-aab6-97d59327937b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-11-19
Reporting Person: Malecek Michael J (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-19 | Ordinary Shares, par value $0.01 per share | M | 10000 | $10.27 | Acquired | 10000 | Direct |
| 2021-11-19 | Ordinary Shares, par value $0.01 per share | S | 10000 | $55 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | Stock Option (Right to Buy) | $10.27 | M | 10000 | Disposed | 2029-07-01 | Ordinary Shares (10000) | Direct |
Footnotes
F1: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The shares subject to the option vest and become exercisable as to 25% of the total number of shares subject to the option on July 1, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.